Filing Details

Accession Number:
0000947871-16-001731
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-30 16:09:15
Reporting Period:
2016-11-28
Filing Date:
2016-11-30
Accepted Time:
2016-11-30 16:09:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326583 Webmd Health Corp. WBMD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1230593 V James Manning C/O Webmd Health Corp.,
395 Hudson Street
New York NY 10014
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-11-28 28,916 $53.55 100,680 No 4 S Direct
Common Stock Acquisiton 2016-11-28 2,222 $30.16 102,902 No 4 M Direct
Common Stock Disposition 2016-11-28 1,253 $53.51 101,649 No 4 F Direct
Common Stock Acquisiton 2016-11-28 4,259 $21.29 105,908 No 4 M Direct
Common Stock Disposition 2016-11-28 1,695 $53.51 104,213 No 4 F Direct
Common Stock Acquisiton 2016-11-28 4,444 $23.54 108,657 No 4 M Direct
Common Stock Disposition 2016-11-28 1,955 $53.53 106,702 No 4 F Direct
Common Stock Acquisiton 2016-11-28 3,300 $41.07 110,002 No 4 M Direct
Common Stock Disposition 2016-11-28 2,534 $53.50 107,468 No 4 F Direct
Common Stock Acquisiton 2016-11-28 6,600 $23.61 114,068 No 4 M Direct
Common Stock Disposition 2016-11-28 2,912 $53.52 111,156 No 4 F Direct
Common Stock Acquisiton 2016-11-28 6,600 $23.59 117,756 No 4 M Direct
Common Stock Disposition 2016-11-28 2,910 $53.52 114,846 No 4 F Direct
Common Stock Acquisiton 2016-11-28 9,900 $38.49 124,746 No 4 M Direct
Common Stock Disposition 2016-11-28 7,123 $53.50 117,623 No 4 F Direct
Common Stock Disposition 2016-11-29 10,000 $53.49 107,623 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-11-28 2,222 $0.00 2,222 $30.16
Common Stock Stock Option (right to buy) Disposition 2016-11-28 4,259 $0.00 4,259 $21.29
Common Stock Stock Option (right to buy) Disposition 2016-11-28 4,444 $0.00 4,444 $23.54
Common Stock Stock Option (right to buy) Disposition 2016-11-28 3,300 $0.00 3,300 $41.07
Common Stock Stock Option (right to buy) Disposition 2016-11-28 6,600 $0.00 6,600 $23.61
Common Stock Stock Option (right to buy) Disposition 2016-11-28 6,600 $0.00 6,600 $23.59
Common Stock Stock Option (right to buy) Disposition 2016-11-28 9,900 $0.00 9,900 $38.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-01-01 No 4 M Direct
0 2018-12-10 No 4 M Direct
0 2019-01-01 No 4 M Direct
0 2018-01-01 No 4 M Direct
0 2018-12-10 No 4 M Direct
0 2019-01-01 No 4 M Direct
0 2020-01-01 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.45 to $53.64 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
  2. Mr. Manning received 969 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 2,222 shares of WebMD Common Stock, with the remaining 1,253 shares being retained by the issuer to pay the exercise price.
  3. Mr. Manning received 2,564 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 4,259 shares of WebMD Common Stock, with the remaining 1,695 shares being retained by the issuer to pay the exercise price.
  4. Mr. Manning received 2,489 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 4,444 shares of WebMD Common Stock, with the remaining 1,955 shares being retained by the issuer to pay the exercise price.
  5. Mr. Manning received 766 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 3,300 shares of WebMD Common Stock, with the remaining 2,534 shares being retained by the issuer to pay the exercise price.
  6. Mr. Manning received 3,688 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 6,600 shares of WebMD Common Stock, with the remaining 2,912 shares being retained by the issuer to pay the exercise price.
  7. Mr. Manning received 3,690 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 6,600 shares of WebMD Common Stock, with the remaining 2,910 shares being retained by the issuer to pay the exercise price.
  8. Mr. Manning received 2,777 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 9,900 shares of WebMD Common Stock, with the remaining 7,123 shares being retained by the issuer to pay the exercise price.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.46 to $53.54 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (9) to this Form 4.
  10. 25% of the shares underlying the options vested on the first anniversary of the grant date and 1/48 of the shares vested monthly thereafter over the next three-year period (fully vested on the 4th anniversary of the grant date). The date of grant for each of these options was ten years prior to the expiration date.
  11. 25% of the shares underlying the options vested on each of the first, second, third and fourth grant date anniversaries. The date of grant for each of these options was ten years prior to the expiration date.